Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation
Clinical trial NCT01285505 · WITHDRAWN
Trial details
- NCT number
- NCT01285505
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2011-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.